缩写名/全名 |
ADV THER
ADVANCES IN THERAPY |
||||||||||||||||
ISSN号 | 0741-238X | ||||||||||||||||
研究方向 | 医学-药学 | ||||||||||||||||
影响因子 | 2015:2.503, 2016:2.709, 2017:3.085, 2018:3.26, 2019:3.871, | ||||||||||||||||
出版国家 | ENGLAND | ||||||||||||||||
出版周期 | Monthly | ||||||||||||||||
年文章数 | 262 | ||||||||||||||||
出版年份 | 1984 | ||||||||||||||||
是否OA | No | ||||||||||||||||
审稿周期(仅供参考) | 较慢,6-12周 |
||||||||||||||||
录用比例 | 较易 | ||||||||||||||||
投稿链接 | http://www.advancesintherapy.com/Home/submit-online | ||||||||||||||||
投稿官网 | http://www.advancesintherapy.com/ | ||||||||||||||||
h-index | 53 | ||||||||||||||||
CiteScore |
|
||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0741-238X%5BISSN%5D | ||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | SOFA Score Can Effectively Predict the Incidence of Sepsis and 30-Day Mortality in Liver Transplant Patients: A Retrospective Study Author: Xiao-Wen Wang, Xing-Guo Niu, Jin-Xiu Li, Si-Sen Zhang, Xian-Fa Jiao Journal: ADVANCES IN THERAPY, 2019, Vol.36, 645-651, DOI:10.1007/s12325-019-0889-z DOI |
2. | Subgroup Analysis for Chinese Patients Included in the INPULSIS<Superscript>®</Superscript> Trials on Nintedanib in Idiopathic Pulmonary Fibrosis Author: Zuojun Xu, Huiping Li, Fuqiang Wen, Chunxue Bai, Ping Chen, Feng Fan, Na Hu, Susanne Stowasser, Jian Kang Journal: ADVANCES IN THERAPY, 2019, Vol.36, 621-631, DOI:10.1007/s12325-019-0887-1 DOI |
3. | Posttraumatic Arterial Priapism Treated with Superselective Embolization: Our Clinical Experience and a Review of the Literature Author: Xiang Wan, Hai-Jun Yao, Da-Chao Zheng, Chong Liu, Shi-Bo Fu, Jian-Hua Guo, Min-Kai Xie, Zhong Wang Journal: ADVANCES IN THERAPY, 2019, Vol.36, 684-690, DOI:10.1007/s12325-019-0875-5 DOI |
4. | A Propensity Score Matched Comparison of Brand and Biosimilar Basal Insulin in Non-Critical Hospitalized Patients with Type 2 Diabetes Mellitus Author: Xia Hu, Lei Zhang, Chao Dong, Yanhu Dong, Jikang Jiang, Weiguo Gao Journal: ADVANCES IN THERAPY, 2019, Vol., , DOI:10.1007/s12325-019-00922-9 DOI |
5. | Thyroid Cancer Benefits the Prognosis of Ovarian Cancer: A SEER-Based Study Author: Qiong Yang, Zhiyong Wu, Xujun He, Leibo Yu, Xiaofei Zhang, Kefeng Lei Journal: ADVANCES IN THERAPY, 2019, Vol., , DOI:10.1007/s12325-019-00918-5 DOI |
6. | The Role of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes in Asia Author: Ju-Ming Lu Journal: ADVANCES IN THERAPY, 2019, Vol.36, 798-805, DOI:10.1007/s12325-019-00914-9 DOI |
7. | Cost-Effectiveness of Alectinib for Patients with Untreated ALK-Positive Non-Small Cell Lung Cancer in China Author: Haijing Guan, Yanan Sheng, Wanjie Guo, Sheng Han, Luwen Shi Journal: ADVANCES IN THERAPY, 2019, Vol., , DOI:10.1007/s12325-019-00908-7 DOI |
8. | Haptoglobin 2-2 Genotype is Associated with More Advanced Disease in Subjects with Non-Alcoholic Steatohepatitis: A Retrospective Study Author: Jingxin Zhou, , Jun Liu, Huiping Sheng, Ningning You, Jin Chen, Xiaoxiao Mi, Wenjun Yang, Shufei Zang, Junping Shi Journal: ADVANCES IN THERAPY, 2019, Vol.36, 880-895, DOI:10.1007/s12325-019-00902-z DOI |
9. | Efficacy, Tolerability and Pharmacokinetic Impact of Aprepitant in Sarcoma Patients Receiving Ifosfamide and Doxorubicin Chemotherapy: A Randomized Controlled Trial Author: Jie Xiong, Guifang Zhao, Shengli Yang, Jing Chen Journal: ADVANCES IN THERAPY, 2019, Vol., , DOI:10.1007/s12325-018-0862-2 DOI |
10. | Efficacy and Safety of CFTR Corrector and Potentiator Combination Therapy in Patients with Cystic Fibrosis for the F508del-CFTR Homozygous Mutation: A Systematic Review and Meta-analysis Author: Hong-xia Wu, Min Zhu, Xiao-feng Xiong, Jia Wei, Kai-quan Zhuo, De-yun Cheng Journal: ADVANCES IN THERAPY, 2018, Vol., , DOI:10.1007/s12325-018-0860-4 DOI |
|
|